How long does acute myeloid leukaemia (AML) treatment last?

Prof. Charles Craddock of the Queen Elizabeth Hospital in Birmingham, UK, describes each treatment traditionally used for the management of acute myeloid leukaemia (AML) and its average length.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting in Orlando, FL.

This programme has been supported by Pfizer, through an unrestricted educational grant to the Patient Empowerment Foundation.